Ana içeriğe geç
med. Alexander Rentschler
Güven puanı 8/100

med. Alexander Rentschler

Urologe Androloge Medikamentose Tumortherapie · dresden

👤 3 yıllık deneyim

5,105+ Patients seen
3 Years in practice
3 Publications
0 Languages spoken

Hakkında

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— med. Alexander Rentschler

Eğitim ve öğretim

  1. 2013–2019 MD · Medicine and Surgery
    Technische Universität München, dresden (DE)
  2. 2019–2023 Residency · Urologe Androloge Medikamentose Tumortherapie
    Universität Hamburg, dresden (DE)

Kariyer ve atamalar

  1. 2023-09–2024-08 Junior consultant
    Technische Universität München Teaching Hospital — Urologe Androloge Medikamentose Tumortherapie

Lisanslar ve sigorta

Tıbbi lisanslar

DE — Bundesärztekammer
#DE-555344 active · expires 2028-12-31

Kurul sertifikaları

European Board of Urologe Androloge Medikamentose Tumortherapie
#EB-A909DE69 · issued 2024 · renewal 2034
Mesleki sorumluluk sigortası: HDI Global · 1,000,000 EUR kapsam · No claims on file

Gerçekleştirilen prosedürler

ProsedürKodToplam sayı
GP consultation 99213 2,161
Annual physical exam 99395 1,111
Vaccination administration 90471 2,023
Minor procedure (skin) 17110 2,568

Hizmetler ve fiyatlandırma

HizmetSüreYöntemFiyat
New patient consultation (60m) 60 dk in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 dk in_clinic|telemed|phone 90.00 EUR
Vaccination administration 120 dk in_clinic 270.00 EUR
Minor procedure (skin) 30 dk in_clinic 360.00 EUR

Ofis, ekip ve uygulamada

Dr. med. Alexander Rentschler
HEADSHOT
Dr. med. Alexander Rentschler in consultation
IN OFFICE
Dr. med. Alexander Rentschler with the team
WITH TEAM
Dr. med. Alexander Rentschler at a conference
CONFERENCE

Videolar

introduction · 118s
Meet Dr. med. Alexander Rentschler

Araştırma ve yayınlar

h-endeksi: 4 · i10: 12

  1. Long-term follow-up of Urologe Androloge Medikamentose Tumortherapie across DE
    Dr. med. Alexander Rentschler, et al. · European Journal of Medicine, 2026
    DOI: 10.8040/euroclin.2026.0 · PMID: 36547412 · alıntılayan 113
  2. Validation of clinical scoring in Urologe Androloge Medikamentose Tumortherapie
    Dr. med. Alexander Rentschler, et al. · European Journal of Medicine, 2025
    DOI: 10.2265/euroclin.2025.1 · PMID: 39355686 · alıntılayan 67

Davetli konuşmalar

  • Practical updates in Urologe Androloge Medikamentose Tumortherapie European Annual Congress (Urologe Androloge Medikamentose Tumortherapie) · Vienna · 2024 · invited
  • Single-centre experience in Urologe Androloge Medikamentose Tumortherapie National Society Meeting · dresden · 2023 · oral abstract

Ödüller ve üyelikler

Ödüller

  • 🏆 Top-rated Urologe Androloge Medikamentose Tumortherapie — dresden · EuroClinics Patient Choice · 2025 · regional

Topluluk üyelikleri

  • WONCA Europe — Family Doctors — Member · 2024 yılından beri
  • national college of family doctors — Member · 2024 yılından beri
  • European Union of Medical Specialists (UEMS) — Member · 2024 yılından beri

Bu doktorun makaleleri

  • Patient education Patient guide to Urologe Androloge Medikamentose Tumortherapie
  • Awareness When should you see a urologe androloge medikamentose tumortherapie?

Uluslararası hastalar için

Koordinatör
Patient liaison · alexander.rentschler@euroclinics.example

Konum

1 etiket

Hasta yorumları

Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
20 – 4.000 karakter

Gönderiler moderasyondan geçer ve herkese açık olarak görünmesi 24-72 saat sürebilir. Hastayı tanımlayan bilgiler dahil edilmemelidir.

Son yorumlar

  • ★★★★★ ✓ Doğrulanmış
    Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
    Anna B.
  • ★★★★★ ✓ Doğrulanmış
    Took time to listen and reviewed all my previous results. I would absolutely recommend.
    Marco V.
  • ★★★★☆ ✓ Doğrulanmış
    Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
    Helena F.

Benzer uzmanlar

Tümünü gözat →